AZD3242
98%
- Product Code: 99677
CAS:
890655-80-8
| Molecular Weight: | 253.32 g./mol | Molecular Formula: | C₁₁H₁₅N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30533444 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
AZD3242 is primarily investigated for its potential therapeutic applications in neurodegenerative diseases, particularly Parkinson's disease. It functions as a selective and potent inhibitor of myeloperoxidase (MPO), an enzyme implicated in neuroinflammation and oxidative stress, which are key contributors to the progression of Parkinson's. By inhibiting MPO, AZD3242 aims to reduce inflammation and oxidative damage in the brain, potentially slowing disease progression and alleviating symptoms. Clinical trials have explored its safety, tolerability, and efficacy in patients, with a focus on its ability to modulate inflammatory pathways and protect neuronal health. Its development represents a promising approach to targeting the underlying mechanisms of neurodegenerative disorders.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white solid |
| PURITY | 97.5-100 |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿2,680.00 |
+
-
|
| 0.005 | 10-20 days | ฿8,000.00 |
+
-
|
| 0.025 | 10-20 days | ฿24,000.00 |
+
-
|
| 0.100 | 10-20 days | ฿65,000.00 |
+
-
|
AZD3242
AZD3242 is primarily investigated for its potential therapeutic applications in neurodegenerative diseases, particularly Parkinson's disease. It functions as a selective and potent inhibitor of myeloperoxidase (MPO), an enzyme implicated in neuroinflammation and oxidative stress, which are key contributors to the progression of Parkinson's. By inhibiting MPO, AZD3242 aims to reduce inflammation and oxidative damage in the brain, potentially slowing disease progression and alleviating symptoms. Clinical trials have explored its safety, tolerability, and efficacy in patients, with a focus on its ability to modulate inflammatory pathways and protect neuronal health. Its development represents a promising approach to targeting the underlying mechanisms of neurodegenerative disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :